Penn Medicine Provider
Radiation Oncology
Karishma Khullar, MD
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman - 2nd Floor

About me

  • Assistant Professor of Clinical Radiation Oncology

Education and training

  • Medical School: University of Cincinnati College of Medicine
  • Residency: Henry Ford Hospital
  • Residency: Rutgers New Jersey Medical School

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Khullar is a Penn Medicine physician.

Qualifications and experience

My research

Khullar K, Deek RA, Nelson B, Gaines D, Corrigan KL, LeCompte MC, Deville C Jr, Deek MP, Jabbour SK. Gender and the Receipt of the Association of Residents in Radiation Oncology Educator of the Year Award , Adv Radiat Oncol, 9(1): 2023,101305


Khullar K, Plascak JJ, Parikh RR Acute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility , Leukemia & Lymphoma, 63(1): 2021,170-178


Khullar K, Hanft S, Mehnert JM, Weiner JP Complete response of brainstem metastasis in BRAF-mutated melanoma without stereotactic radiosurgery after initiation of encorafenib and binimetinib , Melanoma Res, 31(4): 2021,393-396


Modi C, Dragun AE, Henson CF, Jain S, Ahlawat S, Eastwick G, Kubicek GJ, Mezera M, Mulvihill DJ, Perri J, Juneja B, Khullar K, Ennis RD, Haffty BG A Statewide Multi-Institutional Study of Asymptomatic Pretreatment Testing of Radiation Therapy Patients for SARS-CoV-2 in a High-Incidence Region of the United States , Adv Radiat Oncol, 6(4): 2021,100704


Khullar K, Dhawan ST, Nosher J, Jabbour SK Fiducial marker migration following computed tomography-guided placement in the liver: a case report , AME Case Reports, 5: 2021,15


Khullar K & Parikh RR The role of radiotherapy in metastatic prostate cancer , Am J Clin Exp Urol, 7(2): 2021,92-97


Khullar K, Plasack JJ, Drachtman R, Cole PD, Parikh RR Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma , Cancer Medicine, 10(4): 2021,1327-1334


Wang SJ, Khullar K, Kim S, Crayton SH, Yegya-Raman N, Groisberg R, Silk AW, Nosher JL, Malhotra J, Gentile MA, Mehnert JM, Jabbour SK. Cyclooxygenase inhibitor use during checkpoint immunotherapy and effect on time to progression and overall survival for metastatic melanoma and non-small cell lung cancer patients. , Journal for ImmunoTherapy of Cancer: 2020


Wang SJ, Khullar K, Kim S, Yegya-Raman N, Malhotra J, Groisberg R, Crayton SH, Silk AW, Nosher JL, Gentile MA, Mehnert JM, Jabbour SK Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer , J Immunother Cancer, 8(2): 2020,e000889


Khullar K, Rivera-Núñez Z, Jhawar SR, Drachtman R, Cole PD, Hoppe BS, Parikh RR Pediatric hodgkin lymphoma: disparities in survival by race , Leuk Lymphoma, 61(3): 2020,546-556